Urologic Neoplasms D014571

Related MeSH Hierarchy (5)

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Urologic Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urogenital Neoplasms » Urologic Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Urologic Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urologic Neoplasms

Description

Tumors or cancer of the URINARY TRACT in either the male or the female.   MeSH

Subtype Terms (4)

Kidney Neoplasms
288 drugs (141 approved, 147 experimental)

Ureteral Neoplasms
53 drugs (43 approved, 10 experimental)

Urethral Neoplasms
63 drugs (51 approved, 12 experimental)

Urinary Bladder Neoplasms
428 drugs (189 approved, 239 experimental)


Other Experimental Indicated Drugs (3)


Organization Involved with Phase 4 Indications (2)

Organization Involved with Other Experimental Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.